LATEST
Singaporean massage parlour boss added to US ‘worst of the worst criminal aliens list’✦Where the city meets the sea: designing a sustainable future for Qatif’s mangroves✦Indonesia’s Prabowo taps Widodo’s allies as advisers amid falling approval rating✦7-Eleven Shuts All 31 India Stores As Reliance Retail Partnership Ends But Japanese Owner Eyes Comeback✦Shadow minister says Tories would ‘keep political activism out of classrooms’ – UK politics live✦
Tue, Oct 6, 2026
Loading weather...
Markets

GRAIL To Highlight NHS-Galleri, PATHFINDER 2 Findings Amid FDA Review; Stock Up

(RTTNews) - GRAIL, Inc. (GRAL), a healthcare company, will present additional data from the NHS-Galleri trial and PATHFI...

By Dhallo News · October 6, 2026 at 3:07 PM IST

(RTTNews) - GRAIL, Inc. (GRAL), a healthcare company, will present additional data from the NHS-Galleri trial and PATHFINDER 2 study evaluating the Galleri multi-cancer early detection (MCED) test at the Early Detection of Cancer Conference in Edinburgh from October 6-8, 2026, an

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Why Kotak Mahindra Bank shares are outperforming Nifty 50 and Bank Nifty in the last two months? Experts explain

Kotak Mahindra Bank outperformed despite market decline, gaining 10% over two mo...

Read Article »

Stock market prediction for tomorrow: Sensex, Nifty outlook for Wednesday | Kospi, Taiwan cues to watch | 7 Oct 2026

The Indian stock market showed positive momentum on October 6, with the Nifty 50...

Read Article »

Cuba mantiene luces encendidas con energía solar de EE.UU.

Cuando Cuba sufrió su séptimo apagón nacional del año, la fiesta siguió en La Ca...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.